Endostatin gene therapy for liver cancer by a recombinant adenovirus delivery

被引:0
|
作者
Li, Li [1 ]
Huang, Jia-Ling [1 ]
Liu, Qi-Cai [2 ]
Wu, Pei-Hong [1 ]
Liu, Ran-Yi [1 ]
Zeng, Yi-Xin [1 ]
Huang, Wen-Lin [1 ]
机构
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China
[2] Guangzhou Med Coll, Expt Med Res Ctr, Guangzhou 510182, Guangdong, Peoples R China
基金
国家高技术研究发展计划(863计划);
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the expression of adenovirus-mediated human endostatin (Ad/hEndo) gene transfer and its effect on the growth of hepatocellular carcinoma (HCC) BEL-7402 xenografted tumors. METHODS: Immunohistochemistry analysis with an anti-endostatin antibody was preformed to detect endostatin protein expression in HCC BEL-7402 cells infected with Ad/hEndo. MTT assay was used to investigate the effects of Ad/hEndo on proliferation of human umbilical vein endothelial cells (HUVEC). Intra-tumoral injections of 1x10(9) pfu Ad/hEndo was given to treat BEL-7402 xenografted tumors in nude mice once weekly for 6 wk. Mice received injections of Ad/LacZ and DMEM were regarded as control groups. After intra-turmoral administration with Ad/hEndo, the endostatin mRNA expression in tumor tissue was analyzed by Northern blotting, and plasma endostatin levels were determined using enzyme-linked immunosorbent assay (ELISA). RESULTS: High level expression of endostatin gene was detected in the infected HCC BEL-7402 cells. Ad/hEndo significantly inhibited HUVEC cell proliferation by 57.2% at a multiplicity of infection (MOI) of 20. After 6-week treatment with Ad/hEndo, the growth of treated tumors was inhibited by 46.50% compared to the Ad/LacZ control group (t=2.729, P<0.05) and by 48.56% compared to the DMEM control group (t=2.485, P<0.05). The ratio of mean tumor volume in treated animals to mean tumor volume in the control animals (T:C ratio) was less than 50% after 24 d of treatment. Endostatin mRNA in tumor tissue was clearly demonstrated as a band of approximately 1.2 kb, which was the expected size of intact and functional endostatin. Plasma endostatin levels peaked at 87.52 +/- 8.34 ng/mL at d 3 after Ad/hEndo injection, which was significantly higher than the basal level (12.23 +/- 2.54 ng/mL). By d 7, plasma levels dropped to nearly half the peak level (40.34 +/- 4.80 ng/mL). CONCLUSION: Adenovirus-mediated human endostatin gene can successfully express endogenous endostatin in vitro and in vivo, and significantly inhibit the growth of BEL-7402 xenografted liver tumors in nude mice.
引用
收藏
页码:1867 / 1871
页数:5
相关论文
共 50 条
  • [21] Application of recombinant adenovirus for in vivo gene delivery to spinal cord
    Liu, Y
    Himes, BT
    Moul, J
    Huang, WL
    Chow, SY
    Tessler, A
    Fischer, I
    BRAIN RESEARCH, 1997, 768 (1-2) : 19 - 29
  • [22] The gene therapy of bladder cancer by using recombinant adeno-associated virus encoding human endostatin
    Han, RF
    Lu, BX
    Tang, Y
    Wu, CL
    Yao, Z
    Zhang, GJ
    See, WA
    JOURNAL OF UROLOGY, 2005, 173 (04): : 213 - 213
  • [23] Gene therapy of renal cancer using recombinant adeno-associated virus encoding human endostatin
    Sun, Erlin
    Han, Ruifa
    Lu, Bingxin
    ONCOLOGY LETTERS, 2018, 16 (03) : 2789 - 2796
  • [24] POSSIBILITIES OF GENE THERAPY WITH RECOMBINANT ADENOVIRUS IN THE CORTEX AND HIPPOCAMPUS
    Koska, Peter
    Valikovics, Attila
    Kiss-Toth, Eva
    Szalai, Adrienn
    Nagy, Zoltan
    Fodor, Bertalan
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2013, 66 (5-6): : 184 - 189
  • [25] Recombinant adenovirus vectors for cytokine gene therapy in mice
    Kurata, H
    Liu, CB
    Valkova, J
    Koch, AE
    Yssel, H
    Hirabayashi, Y
    Inoue, T
    Yokota, T
    Arai, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (05) : S471 - S484
  • [26] New recombinant adenovirus promises improved gene therapy
    Habeck, M
    LANCET ONCOLOGY, 2002, 3 (03): : 134 - 134
  • [27] Gold Nanoparticle–Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy
    Wei Li
    Xiaoxu Zhao
    Bin Du
    Xin Li
    Shuhao Liu
    Xiao-Yan Yang
    Hui Ding
    Wende Yang
    Fan Pan
    Xiaobo Wu
    Li Qin
    Yunlong Pan
    Scientific Reports, 6
  • [28] A recombinant adenovirus for targeted gene therapy of pulmonary inflammation
    Alberti, Michael
    Deshane, Jessy
    Pereboeva, Larisa
    Tsuruta, Yuko
    Abraham, Ed
    Chaplin, David
    Gerson, Stanton
    Curiel, David
    Roth, Justin
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [29] Adenovirus-mediated gene transfer of VEGF and endostatin influences liver regeneration in mice
    Redaelli, C
    Sauter, B
    Ledermann, M
    Schmidt, K
    Dufour, JF
    JOURNAL OF HEPATOLOGY, 2002, 36 : 79 - 79
  • [30] Adenovirus-mediated gene transfer of VEGF and endostatin influences liver regeneration in mice
    Redaelli, CA
    Wagner, M
    Sauter, B
    Dufour, JF
    GASTROENTEROLOGY, 2002, 122 (04) : A651 - A651